NCT06838364 Comparison of the Effectiveness of Ultrasound-guided Techniques and Infrared Illumination, Compared With the Standard Approach to Peripheral Venous Line Placement in People With Difficult Venous Access
| NCT ID | NCT06838364 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Poitiers University Hospital |
| Condition | Peripheral Venous Catheterization |
| Study Type | INTERVENTIONAL |
| Enrollment | 264 participants |
| Start Date | 2025-04-08 |
| Primary Completion | 2028-04-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 264 participants in total. It began in 2025-04-08 with a primary completion date of 2028-04-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Peripheral venous catheterization (PVC) is the most common invasive procedure in healthcare worldwide. Improving the success rate of PVC on the first attempt is crucial for patients, as it impacts pain, anxiety, the risk of extravasation, rapid access to care, and the patient-provider relationship. For healthcare providers, a higher success rate enhances self-confidence and autonomy, while institutions benefit from improved reputation and reduced costs. In the Poitiers hosptial, one in ten catheters is used in imaging services, with CT scan departments accounting for 66.3% of catheter usage due to iodinated contrast injections. Literature suggests two techniques to enhance PVC success: ultrasound-guided and infrared illumination methods. These techniques appear effective primarily for patients with difficult venous access. Additionally, the A-DIVA clinical score has been developed to predict first-attempt success rates. However, no studies in Europe have compared the effectiveness of these two techniques in imaging settings or based on the A-DIVA score. This study aims to identify the most effective technique for PVC in patients with difficult venous access.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 or over * Patient with a CT scan appointment and a medical prescription requiring a peripheral venous line. * Patient with an A-DIVA score greater than or equal to 2. * Patient able and willing to comply with all study procedures. * Patient covered by a social security scheme or covered through a third party. * Patients who have given their free and informed written consent following clear and fair information about the study. Exclusion Criteria: * Patient with a contraindication to VVP insertion: * Arm with arteriovenous fistula * Limb with an orthopaedic or vascular prosthesis * Previous mastectomy, axillary lymph node dissection or homolateral radiotherapy of the arm * Paralysed limb * Presence of haematomas or puncture site wounds * Limb with phlebitis or infection * Patients already included in the study * Persons benefiting from enhanced protection, i.e. minors, persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social establishment, pregnant or breast-feeding women, adults under legal protection and patients in emergency situations.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06838364 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Peripheral Venous Catheterization. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06838364 currently recruiting?
Yes, NCT06838364 is actively recruiting participants. Contact the research team at guillaume.davy@chu-poitiers.fr for enrollment information.
Where is the NCT06838364 trial being conducted?
This trial is being conducted at Poitiers, France.
Who is sponsoring the NCT06838364 clinical trial?
NCT06838364 is sponsored by Poitiers University Hospital. The trial plans to enroll 264 participants.